CRLBF — Cresco Labs Cashflow Statement
0.000.00%
Last trade - 00:00- $380.58m
- $795.98m
- $724.34m
- 66
- 97
- 26
- 68
Annual cashflow statement for Cresco Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -92.8 | -297 | -216 | -180 | -60.5 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 59.1 | 337 | 174 | 193 | 97.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.23 | -29.1 | 13.5 | 15.2 | 29.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.85 | 14.5 | 18.7 | 58.6 | 126 |
| Capital Expenditures | -89.3 | -97.1 | -86.1 | -57.9 | -23.5 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 24.5 | -66.9 | 49.6 | 13.3 | -1.74 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -64.7 | -164 | -36.6 | -44.6 | -25.2 |
| Financing Cash Flow Items | -34.6 | -76.4 | -87.4 | -43.6 | -27.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 161 | 235 | -86.6 | -26.9 | -71.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 87.8 | 85.3 | -105 | -13 | 29 |